These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Untch BR; Olson JA Surg Oncol Clin N Am; 2006 Jul; 15(3):661-79, x. PubMed ID: 16882503 [TBL] [Abstract][Full Text] [Related]
25. Whole body MRI and PET/CT in haematological malignancies. Lin C; Luciani A; Itti E; Haioun C; Rahmouni A Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S88-93. PubMed ID: 17921084 [TBL] [Abstract][Full Text] [Related]
26. [CT-PET and evaluation of therapy response. is the size really important?]. Fernández A; Duch J; Flotats A; Camacho V; Estorch M; Carrió I Rev Esp Med Nucl; 2010; 29(4):184-8. PubMed ID: 20638956 [No Abstract] [Full Text] [Related]
28. Geriatrics and haematological malignancies: is comprehensive geriatric assessment a useful tool? Noens L Eur J Cancer; 2011 Sep; 47 Suppl 3():S362-3. PubMed ID: 21944016 [No Abstract] [Full Text] [Related]
29. Evolving role of radiation therapy for hematologic malignancies. Lee CK Hematol Oncol Clin North Am; 2006 Apr; 20(2):471-503. PubMed ID: 16730303 [TBL] [Abstract][Full Text] [Related]
30. Manual for coding and reporting haematological malignancies. HAEMACARE Working Group Tumori; 2010; 96(4):i-A32. PubMed ID: 20968151 [No Abstract] [Full Text] [Related]
31. Haematological malignancies: the rationale for integrated haematopathology services, key elements of organization and wider contribution to patient care. Ireland R Histopathology; 2011 Jan; 58(1):145-54. PubMed ID: 21261689 [TBL] [Abstract][Full Text] [Related]
32. Imaging features of haematological malignancies of kidneys. Sandrasegaran K; Menias CO; Verma S; Abdelbaki A; Shaaban A; Elsayes KM Clin Radiol; 2016 Mar; 71(3):195-202. PubMed ID: 26688550 [TBL] [Abstract][Full Text] [Related]
33. The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation. Lowenthal RM; Tegg EM; Dickinson JL Transfus Apher Sci; 2013 Oct; 49(2):113-5. PubMed ID: 23968988 [TBL] [Abstract][Full Text] [Related]
34. Immune therapy in haematological malignancies. Tallman MS Best Pract Res Clin Haematol; 2006; 19(4):635-6. PubMed ID: 16997173 [No Abstract] [Full Text] [Related]
35. Biological markers in haematological malignancies. Lemal R; Tournilhac O; Bay JO Bull Cancer; 2014 Jun; 101 Suppl 1():S7-11. PubMed ID: 24966076 [TBL] [Abstract][Full Text] [Related]
36. The development of haematopathology laboratories: a possible model for other pathology services. Jack AS; Morgan GJ J Pathol; 1998 Mar; 184(3):231-3. PubMed ID: 9614372 [TBL] [Abstract][Full Text] [Related]
37. [Geriatric assessment for elderly patients with haematological malignancies]. Chaïbi P; Mitha N Rev Med Interne; 2012 Dec; 33 Suppl 2():A24-7. PubMed ID: 23098884 [No Abstract] [Full Text] [Related]
38. [Disease profiling in haemato-oncology]. Huijgens PC Tijdschr Psychiatr; 2012; 54(11):921-5. PubMed ID: 23138618 [TBL] [Abstract][Full Text] [Related]
39. Haematological cancers in African children: progress and challenges. Molyneux E; Scanlan T; Chagaluka G; Renner L Br J Haematol; 2017 Jun; 177(6):971-978. PubMed ID: 28599352 [TBL] [Abstract][Full Text] [Related]
40. ESH-SIOG International Conference on Haematological Malignancies in the Elderly. Balducci L Expert Rev Hematol; 2010 Dec; 3(6):675-7. PubMed ID: 21091143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]